Literature DB >> 8339417

Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen.

H G Klues1, M A Proschan, A L Dollar, P Spirito, W C Roberts, B J Maron.   

Abstract

BACKGROUND: In patients with hypertrophic cardiomyopathy, obstruction to left ventricular outflow is produced by systolic anterior motion of the mitral valve. In many of these patients, the mitral leaflets are elongated and increased in overall size. Mitral valve size may be responsible, in part, for the presence and magnitude of the outflow gradient and the pattern of systolic anterior motion of the leaflets. It may also influence the effectiveness of ventricular septal myotomy-myectomy in relieving subaortic obstruction. Therefore, the present study was undertaken to determine whether mitral valve dimensions could be assessed in quantitative terms from the echocardiogram in patients with hypertrophic cardiomyopathy. METHODS AND
RESULTS: A group of 37 patients with hypertrophic cardiomyopathy was selected for this study by virtue of having a high-quality transthoracic or intraoperative echocardiogram suitable for certain quantitative measurements from stop-frame images as well as a morphologically intact mitral valve specimen (removed during surgery). Seven measurements of mitral valve dimensions were obtained from the two-dimensional and M-mode echocardiograms. A univariate regression analysis identified the mitral valve opening area as the best single predictor of actual mitral leaflet area measured from the specimen (r2 = .75; r = .87). The linear relation between mitral valve opening area as assessed by two-dimensional echocardiography and actual mitral leaflet area measured from the mitral valve specimen accounted for approximately 75% of the variability in mitral leaflet area. With such statistical models, it was possible to reliably identify from the echocardiogram enlarged mitral valves (> or = 12.0 cm2) in 16 of 19 patients (84%) and normal-sized valves in 15 of 18 patients (83%).
CONCLUSIONS: In a selected group of patients with obstructive hypertrophic cardiomyopathy, a model derived from a regression analysis of quantitative echocardiographic measurements permitted (with good precision) estimation of actual mitral leaflet area and consequently overall mitral valve size and the discrimination of enlarged from normal-sized mitral valves.

Entities:  

Mesh:

Year:  1993        PMID: 8339417     DOI: 10.1161/01.cir.88.2.548

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy; Karim Said; Gehan Magdi; Fatma Abul Enein; Robert George; Alessandra Rossi; Iacopo Olivotto; Franco Cecchi
Journal:  J Cardiovasc Transl Res       Date:  2009-11-26       Impact factor: 4.132

2.  Extraction of open-state mitral valve geometry from CT volumes.

Authors:  Lennart Tautz; Mathias Neugebauer; Markus Hüllebrand; Katharina Vellguth; Franziska Degener; Simon Sündermann; Isaac Wamala; Leonid Goubergrits; Titus Kuehne; Volkmar Falk; Anja Hennemuth
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-08-03       Impact factor: 2.924

3.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

Authors:  W J McKenna; P Spirito; M Desnos; O Dubourg; M Komajda
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

Review 4.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

Review 5.  Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.

Authors:  C Charles Jain; Darrell B Newman; Jeffrey B Geske
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

6.  Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.

Authors:  Hannah G van Velzen; Arend F L Schinkel; Myrthe E Menting; Annemien E van den Bosch; Michelle Michels
Journal:  J Ultrasound       Date:  2018-06-06

Review 7.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

8.  Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.

Authors:  Mika Tarkiainen; Petri Sipola; Mikko Jalanko; Tiina Heliö; Mika Laine; Vesa Järvinen; Kaisu Häyrinen; Kirsi Lauerma; Johanna Kuusisto
Journal:  J Cardiovasc Magn Reson       Date:  2016-06-04       Impact factor: 5.364

9.  Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy.

Authors:  Hyemoon Chung; Yoonjung Kim; Chul-Hwan Park; Jong-Youn Kim; Pil-Ki Min; Young Won Yoon; Tae Hoon Kim; Byoung Kwon Lee; Bum-Kee Hong; Se-Joong Rim; Hyuck Moon Kwon; Kyung-A Lee; Eui-Young Choi
Journal:  Cardiovasc Ultrasound       Date:  2019-10-28       Impact factor: 2.062

Review 10.  Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings.

Authors:  Rafaela Soler; Cristina Méndez; Esther Rodríguez; Roberto Barriales; Juan Pablo Ochoa; Lorenzo Monserrat
Journal:  Insights Imaging       Date:  2018-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.